MedTrace Logo

Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)

NCT01419587 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-01-08

No results posted yet for this study

Summary

This study investigates if using a very low carbohydrate diet during combined chemotherapy and radiation therapy is safe and if it can be tolerated by lung cancer patients.

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

DIETARY_SUPPLEMENT

Ketogenic diet

A ketogenic diet matching the fat to carbohydrate + proteins in Keto-Cal(R) 4:1 by Nutricia North America.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • Nutricia North America

    collaborator INDUSTRY

  • University of Iowa

    lead OTHER

Principal Investigators

  • Bryan G. Allen, MD, PhD · The Department of Radiation Oncology, The University of Iowa

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2017-06-30
Completion
2017-07-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419587 on ClinicalTrials.gov